查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1769901

非侵入性产前检测市场－全球产业分析、规模、份额、成长、趋势及预测（2025-2035）

Non-invasive Prenatal Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
出版日期: | 出版商: Transparency Market Research | 英文 240 Pages | 商品交期: 2-10个工作天内

价格

非侵入性产前检测市场-报告范围

TMR 的全球非侵入性产前检测市场报告研究了过去和当前的成长趋势及机会，旨在深入了解 2025 年至 2035 年预测期内的市场指标。报告提供了 2019 年至 2035 年期间全球无创产前检测市场的收入，以 2025 年为基准年，2035 年为预测年。该报告还提供了 2025 年至 2035 年全球无创产前检测市场的年复合成长率(CAGR%)。

本报告经过广泛的调查后编写。主要研究工作包括分析师对关键意见领袖、产业领导者和舆论领袖进行访谈。次要研究则参考了主要参与者的产品资料、年度报告、新闻稿和相关文件，以了解非侵入性产前检测市场。

市场概况
2024 年的市场价值 47亿美元
2035年的市场价值 132亿美元
复合年增长率 9.5%

本报告深入探讨了全球无创产前检测市场的竞争格局。该报告确定了全球无创产前检测市场的主要参与者，并根据不同特征对每家公司进行了分析。本报告对全球无创产前检测市场参与者的分析涵盖了公司概况、财务状况、近期发展和 SWOT 分析。

目录

第一章：前言

第二章：假设与研究方法

第三章：执行摘要：全球市场

第四章：市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2020年至2035年全球无创产前检测市场分析与预测

第五章：关键见解

  • 技术进步
  • 定价趋势
  • 主要地区/国家的监管格局
  • 波特五力分析
  • PESTEL分析
  • 价值链分析
  • 最终用户的关键购买指标
  • 重要产业事件（合作伙伴关係、协作、产品审批、併购、融资和投资）
  • 竞争对手提供的产品基准化分析

第六章：全球市场分析与预测：依测试类型

  • 介绍和定义
  • 主要发现/进展
  • 2020 年至 2035 年按测试类型分類的市场价值预测
    • 无细胞DNA筛检测试
    • 血清标记筛检测试
    • 神经管缺陷检查
    • 超音波检查
  • 各测试类型的市场吸引力

第七章：全球市场分析与预测：依产品

  • 介绍和定义
  • 主要发现/进展
  • 2020 年至 2035 年各产品市场价值预测
    • 仪器
    • 试剂盒和试剂
  • 各产品市场吸引力

第八章：全球市场分析与预测：依技术

  • 介绍和定义
  • 主要发现/进展
  • 2020 年至 2035 年各技术市场价值预测
    • 全基因组定序
    • SNP分析
    • 微阵列分析
    • 滚环扩增
  • 按技术分類的市场吸引力

第九章：全球市场分析与预测：按适应症

  • 介绍和定义
  • 主要发现/进展
  • 2020 年至 2035 年各适应症市场价值预测
    • 唐氏症（21三体）
    • 爱德华兹氏症候群（18三体）
    • 帕陶症候群（13三体症）
    • 特纳氏症（单体性X/XO）
    • 克莱恩费尔特症候群（XXY）
    • 雅各布症候群（XYY）
    • 性别认同
    • 其他（Triple X 等）
  • 市场吸引力（按适应症）

第十章：全球市场分析与预测：依最终用户

  • 介绍和定义
  • 主要发现/进展
  • 2020 年至 2035 年终端用户市场价值预测
    • 医院
    • 专科诊所
    • 诊断实验室
    • 其他（研究机构等）
  • 最终用户的市场吸引力

第 11 章：全球市场分析与预测：按地区

  • 主要发现
  • 各地区市场价值预测
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 各地区市场吸引力

第十二章：北美市场分析与预测

  • 我们
  • 加拿大

第十三章：欧洲市场分析与预测

  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 欧洲其他地区

第十四章：亚太市场分析与预测

  • 中国
  • 印度
  • 日本
  • 澳洲和纽西兰
  • 亚太其他地区

第十五章：拉丁美洲市场分析与预测

  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区

第十六章：中东与非洲市场分析与预测

  • 海湾合作委员会国家
  • 南非
  • 中东和非洲其他地区

第 17 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 各公司市占率分析（2024 年）
  • 公司简介
    • F. Hoffmann-La Roche Ltd
    • Natera, Inc.
    • Illumina, Inc
    • PerkinElmer Inc.
    • Eurofins LifeCodexx AG
    • IGENOMIX
    • Pacific Biosciences
    • BGI
    • Laboratory Corporation of America Holdings
    • Agilent Technologies, Inc.
    • Berry Genetics Inc.
Product Code: TMRGL374

Non-invasive Prenatal Testing Market - Scope of Report

TMR's report on the global non-invasive prenatal testing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global non-invasive prenatal testing market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global non-invasive prenatal testing market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the non-invasive prenatal testing market.

Market Snapshot
Market Value in 2024US$ 4.7 Bn
Market Value in 2035US$ 13.2 Bn
CAGR9.5%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global non-invasive prenatal testing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global non-invasive prenatal testing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global non-invasive prenatal testing market.

The report delves into the competitive landscape of the global non-invasive prenatal testing market. Key players operating in the global non-invasive prenatal testing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global non-invasive prenatal testing market profiled in this report.

Key Questions Answered in Global non-invasive prenatal testing Market Report:

  • What is the sales/revenue generated by non-invasive prenatal testing across all regions during the forecast period?
  • What are the opportunities in the global non-invasive prenatal testing market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Non-invasive Prenatal Testing Market - Research Objectives and Research Approach

The comprehensive report on the global non-invasive prenatal testing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global non-invasive prenatal testing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global non-invasive prenatal testing market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Non-invasive Prenatal Testing Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Non-invasive Prenatal Testing Market Analysis and Forecasts, 2020 to 2035

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. Pricing Trends
  • 5.3. Regulatory Landscape across Key Regions / Countries
  • 5.4. PORTER's Five Forces Analysis
  • 5.5. PESTEL Analysis
  • 5.6. Value Chain Analysis
  • 5.7. Key Purchase Metrics for End-users
  • 5.8. Key Industry Events (Partnership, Collaborations, Product approvals, merger & acquisitions, funding and investments)
  • 5.9. Benchmarking of the Product Offered by the Competitors

6. Global Non-invasive Prenatal Testing Market Analysis and Forecasts, By Test Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Test Type, 2020 to 2035
    • 6.3.1. Cell-Free DNA Screening Test
    • 6.3.2. Serum Marker Screening Test
    • 6.3.3. Neural Tube Defects Test
    • 6.3.4. Ultrasonography
  • 6.4. Market Attractiveness By Test Type

7. Global Non-invasive Prenatal Testing Market Analysis and Forecasts, By Product

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Product, 2020 to 2035
    • 7.3.1. Instruments
    • 7.3.2. Kits & Reagents
  • 7.4. Market Attractiveness By Product

8. Global Non-invasive Prenatal Testing Market Analysis and Forecasts, By Technology

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Technology, 2020 to 2035
    • 8.3.1. Whole-Genome Sequencing
    • 8.3.2. SNP Analysis
    • 8.3.3. Microarray Analysis
    • 8.3.4. Rolling Circle Amplification
  • 8.4. Market Attractiveness By Technology

9. Global Non-invasive Prenatal Testing Market Analysis and Forecasts, By Indication

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By Indication, 2020 to 2035
    • 9.3.1. Down Syndrome (trisomy 21)
    • 9.3.2. Edwards syndrome (trisomy 18)
    • 9.3.3. Patau syndrome (trisomy 13)
    • 9.3.4. Turner Syndrom (Monosomy X/XO)
    • 9.3.5. Klinefelter Syndrome (XXY)
    • 9.3.6. Jacob's Syndrome (XYY)
    • 9.3.7. Gender Identification
    • 9.3.8. Others (Triple X, etc.)
  • 9.4. Market Attractiveness By Indication

10. Global Non-invasive Prenatal Testing Market Analysis and Forecasts, By End-user

  • 10.1. Introduction & Definition
  • 10.2. Key Findings / Developments
  • 10.3. Market Value Forecast By End-user, 2020 to 2035
    • 10.3.1. Hospitals
    • 10.3.2. Specialty Clinics
    • 10.3.3. Diagnostics Laboratories
    • 10.3.4. Others (Research Institutes, etc.)
  • 10.4. Market Attractiveness By End-user

11. Global Non-invasive Prenatal Testing Market Analysis and Forecasts, By Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast By Region
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness By Region

12. North America Non-invasive Prenatal Testing Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Test Type, 2020 to 2035
    • 12.2.1. Cell-Free DNA Screening Test
    • 12.2.2. Serum Marker Screening Test
    • 12.2.3. Neural Tube Defects Test
    • 12.2.4. Ultrasonography
  • 12.3. Market Value Forecast By Product, 2020 to 2035
    • 12.3.1. Instruments
    • 12.3.2. Kits & Reagents
  • 12.4. Market Value Forecast By Technology, 2020 to 2035
    • 12.4.1. Whole-Genome Sequencing
    • 12.4.2. SNP Analysis
    • 12.4.3. Microarray Analysis
    • 12.4.4. Rolling Circle Amplification
  • 12.5. Market Value Forecast By Indication, 2020 to 2035
    • 12.5.1. Down Syndrome (trisomy 21)
    • 12.5.2. Edwards syndrome (trisomy 18)
    • 12.5.3. Patau syndrome (trisomy 13)
    • 12.5.4. Turner Syndrom (Monosomy X/XO)
    • 12.5.5. Klinefelter Syndrome (XXY)
    • 12.5.6. Jacob's Syndrome (XYY)
    • 12.5.7. Gender Identification
    • 12.5.8. Others (Triple X, etc.)
  • 12.6. Market Value Forecast By End-user, 2020 to 2035
    • 12.6.1. Hospitals
    • 12.6.2. Specialty Clinics
    • 12.6.3. Diagnostics Laboratories
    • 12.6.4. Others (Research Institutes, etc.)
  • 12.7. Market Value Forecast By Country, 2020 to 2035
    • 12.7.1. U.S.
    • 12.7.2. Canada
  • 12.8. Market Attractiveness Analysis
    • 12.8.1. By Test Type
    • 12.8.2. By Product
    • 12.8.3. By Technology
    • 12.8.4. By Indication
    • 12.8.5. By End-user
    • 12.8.6. By Country

13. Europe Non-invasive Prenatal Testing Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Test Type, 2020 to 2035
    • 13.2.1. Cell-Free DNA Screening Test
    • 13.2.2. Serum Marker Screening Test
    • 13.2.3. Neural Tube Defects Test
    • 13.2.4. Ultrasonography
  • 13.3. Market Value Forecast By Product, 2020 to 2035
    • 13.3.1. Instruments
    • 13.3.2. Kits & Reagents
  • 13.4. Market Value Forecast By Technology, 2020 to 2035
    • 13.4.1. Whole-Genome Sequencing
    • 13.4.2. SNP Analysis
    • 13.4.3. Microarray Analysis
    • 13.4.4. Rolling Circle Amplification
  • 13.5. Market Value Forecast By Indication, 2020 to 2035
    • 13.5.1. Down Syndrome (trisomy 21)
    • 13.5.2. Edwards syndrome (trisomy 18)
    • 13.5.3. Patau syndrome (trisomy 13)
    • 13.5.4. Turner Syndrom (Monosomy X/XO)
    • 13.5.5. Klinefelter Syndrome (XXY)
    • 13.5.6. Jacob's Syndrome (XYY)
    • 13.5.7. Gender Identification
    • 13.5.8. Others (Triple X, etc.)
  • 13.6. Market Value Forecast By End-user ,2020 to 2035
    • 13.6.1. Hospitals
    • 13.6.2. Specialty Clinics
    • 13.6.3. Diagnostics Laboratories
    • 13.6.4. Others (Research Institutes, etc.)
  • 13.7. Market Value Forecast By Country/Sub-region ,2020 to 2035
    • 13.7.1. Germany
    • 13.7.2. U.K.
    • 13.7.3. France
    • 13.7.4. Italy
    • 13.7.5. Spain
    • 13.7.6. Rest of Europe
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Test Type
    • 13.8.2. By Product
    • 13.8.3. By Technology
    • 13.8.4. By Indication
    • 13.8.5. By End-user
    • 13.8.6. By Country/Sub-region

14. Asia Pacific Non-invasive Prenatal Testing Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Test Type, 2020 to 2035
    • 14.2.1. Cell-Free DNA Screening Test
    • 14.2.2. Serum Marker Screening Test
    • 14.2.3. Neural Tube Defects Test
    • 14.2.4. Ultrasonography
  • 14.3. Market Value Forecast By Product, 2020 to 2035
    • 14.3.1. Instruments
    • 14.3.2. Kits & Reagents
  • 14.4. Market Value Forecast By Technology, 2020 to 2035
    • 14.4.1. Whole-Genome Sequencing
    • 14.4.2. SNP Analysis
    • 14.4.3. Microarray Analysis
    • 14.4.4. Rolling Circle Amplification
  • 14.5. Market Value Forecast By Indication, 2020 to 2035
    • 14.5.1. Down Syndrome (trisomy 21)
    • 14.5.2. Edwards syndrome (trisomy 18)
    • 14.5.3. Patau syndrome (trisomy 13)
    • 14.5.4. Turner Syndrom (Monosomy X/XO)
    • 14.5.5. Klinefelter Syndrome (XXY)
    • 14.5.6. Jacob's Syndrome (XYY)
    • 14.5.7. Gender Identification
    • 14.5.8. Others (Triple X, etc.)
  • 14.6. Market Value Forecast By End-user, 2020 to 2035
    • 14.6.1. Hospitals
    • 14.6.2. Specialty Clinics
    • 14.6.3. Diagnostics Laboratories
    • 14.6.4. Others (Research Institutes, etc.)
  • 14.7. Market Value Forecast By Country/Sub-region, 2020 to 2035
    • 14.7.1. China
    • 14.7.2. India
    • 14.7.3. Japan
    • 14.7.4. Australia & New Zealand
    • 14.7.5. Rest of Asia Pacific
  • 14.8. Market Attractiveness Analysis
    • 14.8.1. By Test Type
    • 14.8.2. By Product
    • 14.8.3. By Technology
    • 14.8.4. By Indication
    • 14.8.5. By End-user
    • 14.8.6. By Country/Sub-region

15. Latin America Non-invasive Prenatal Testing Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Test Type, 2020 to 2035
    • 15.2.1. Cell-Free DNA Screening Test
    • 15.2.2. Serum Marker Screening Test
    • 15.2.3. Neural Tube Defects Test
    • 15.2.4. Ultrasonography
  • 15.3. Market Value Forecast By Product, 2020 to 2035
    • 15.3.1. Instruments
    • 15.3.2. Kits & Reagents
  • 15.4. Market Value Forecast By Technology ,2020 to 2035
    • 15.4.1. Whole-Genome Sequencing
    • 15.4.2. SNP Analysis
    • 15.4.3. Microarray Analysis
    • 15.4.4. Rolling Circle Amplification
  • 15.5. Market Value Forecast By Indication, 2020 to 2035
    • 15.5.1. Down Syndrome (trisomy 21)
    • 15.5.2. Edwards syndrome (trisomy 18)
    • 15.5.3. Patau syndrome (trisomy 13)
    • 15.5.4. Turner Syndrom (Monosomy X/XO)
    • 15.5.5. Klinefelter Syndrome (XXY)
    • 15.5.6. Jacob's Syndrome (XYY)
    • 15.5.7. Gender Identification
    • 15.5.8. Others (Triple X, etc.)
  • 15.6. Market Value Forecast By End-user, 2020 to 2035
    • 15.6.1. Hospitals
    • 15.6.2. Specialty Clinics
    • 15.6.3. Diagnostics Laboratories
    • 15.6.4. Others (Research Institutes, etc.)
  • 15.7. Market Value Forecast By Country/Sub-region, 2020 to 2035
    • 15.7.1. Brazil
    • 15.7.2. Mexico
    • 15.7.3. Rest of Latin America
  • 15.8. Market Attractiveness Analysis
    • 15.8.1. By Test Type
    • 15.8.2. By Product
    • 15.8.3. By Technology
    • 15.8.4. By Indication
    • 15.8.5. By End-user
    • 15.8.6. By Country/Sub-region

16. Middle East & Africa Non-invasive Prenatal Testing Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast By Test Type, 2020 to 2035
    • 16.2.1. Cell-Free DNA Screening Test
    • 16.2.2. Serum Marker Screening Test
    • 16.2.3. Neural Tube Defects Test
    • 16.2.4. Ultrasonography
  • 16.3. Market Value Forecast By Product, 2020 to 2035
    • 16.3.1. Instruments
    • 16.3.2. Kits & Reagents
  • 16.4. Market Value Forecast By Technology, 2020 to 2035
    • 16.4.1. Whole-Genome Sequencing
    • 16.4.2. SNP Analysis
    • 16.4.3. Microarray Analysis
    • 16.4.4. Rolling Circle Amplification
  • 16.5. Market Value Forecast By Indication, 2020 to 2035
    • 16.5.1. Down Syndrome (trisomy 21)
    • 16.5.2. Edwards syndrome (trisomy 18)
    • 16.5.3. Patau syndrome (trisomy 13)
    • 16.5.4. Turner Syndrom (Monosomy X/XO)
    • 16.5.5. Klinefelter Syndrome (XXY)
    • 16.5.6. Jacob's Syndrome (XYY)
    • 16.5.7. Gender Identification
    • 16.5.8. Others (Triple X, etc.)
  • 16.6. Market Value Forecast By End-user, 2020 to 2035
    • 16.6.1. Hospitals
    • 16.6.2. Specialty Clinics
    • 16.6.3. Diagnostics Laboratories
    • 16.6.4. Others (Research Institutes, etc.)
  • 16.7. Market Value Forecast By Country/Sub-region ,2020 to 2035
    • 16.7.1. GCC Countries
    • 16.7.2. South Africa
    • 16.7.3. Rest of Middle East & Africa
  • 16.8. Market Attractiveness Analysis
    • 16.8.1. By Test Type
    • 16.8.2. By Product
    • 16.8.3. By Technology
    • 16.8.4. By Indication
    • 16.8.5. By End-user
    • 16.8.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 17.2. Market Share Analysis By Company (2024)
  • 17.3. Company Profiles
    • 17.3.1. F. Hoffmann-La Roche Ltd
      • 17.3.1.1. Company Overview
      • 17.3.1.2. Financial Overview
      • 17.3.1.3. Product Portfolio
      • 17.3.1.4. Business Strategies
      • 17.3.1.5. Recent Developments
    • 17.3.2. Natera, Inc.
      • 17.3.2.1. Company Overview
      • 17.3.2.2. Financial Overview
      • 17.3.2.3. Product Portfolio
      • 17.3.2.4. Business Strategies
      • 17.3.2.5. Recent Developments
    • 17.3.3. Illumina, Inc
      • 17.3.3.1. Company Overview
      • 17.3.3.2. Financial Overview
      • 17.3.3.3. Product Portfolio
      • 17.3.3.4. Business Strategies
      • 17.3.3.5. Recent Developments
    • 17.3.4. PerkinElmer Inc.
      • 17.3.4.1. Company Overview
      • 17.3.4.2. Financial Overview
      • 17.3.4.3. Product Portfolio
      • 17.3.4.4. Business Strategies
      • 17.3.4.5. Recent Developments
    • 17.3.5. Eurofins LifeCodexx AG
      • 17.3.5.1. Company Overview
      • 17.3.5.2. Financial Overview
      • 17.3.5.3. Product Portfolio
      • 17.3.5.4. Business Strategies
      • 17.3.5.5. Recent Developments
    • 17.3.6. IGENOMIX
      • 17.3.6.1. Company Overview
      • 17.3.6.2. Financial Overview
      • 17.3.6.3. Product Portfolio
      • 17.3.6.4. Business Strategies
      • 17.3.6.5. Recent Developments
    • 17.3.7. Pacific Biosciences
      • 17.3.7.1. Company Overview
      • 17.3.7.2. Financial Overview
      • 17.3.7.3. Product Portfolio
      • 17.3.7.4. Business Strategies
      • 17.3.7.5. Recent Developments
    • 17.3.8. BGI
      • 17.3.8.1. Company Overview
      • 17.3.8.2. Financial Overview
      • 17.3.8.3. Product Portfolio
      • 17.3.8.4. Business Strategies
      • 17.3.8.5. Recent Developments
    • 17.3.9. Laboratory Corporation of America Holdings
      • 17.3.9.1. Company Overview
      • 17.3.9.2. Financial Overview
      • 17.3.9.3. Product Portfolio
      • 17.3.9.4. Business Strategies
      • 17.3.9.5. Recent Developments
    • 17.3.10. Agilent Technologies, Inc.
      • 17.3.10.1. Company Overview
      • 17.3.10.2. Financial Overview
      • 17.3.10.3. Product Portfolio
      • 17.3.10.4. Business Strategies
      • 17.3.10.5. Recent Developments
    • 17.3.11. Berry Genetics Inc.
      • 17.3.11.1. Company Overview
      • 17.3.11.2. Financial Overview
      • 17.3.11.3. Product Portfolio
      • 17.3.11.4. Business Strategies
      • 17.3.11.5. Recent Developments

List of Tables

  • Table 01: Global Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Test Type, 2020 to 2035
  • Table 02: Global Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Product, 2020 to 2035
  • Table 03: Global Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Technology, 2020 to 2035
  • Table 04: Global Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
  • Table 05: Global Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 06: Global Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Region, 2020 to 2035
  • Table 07: North America - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, by Country, 2020 to 2035
  • Table 08: North America - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Test Type, 2020 to 2035
  • Table 09: North America - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Product, 2020 to 2035
  • Table 10: North America - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Technology, 2020 to 2035
  • Table 11: North America - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
  • Table 12: North America - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 13: Europe - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 14: Europe - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Test Type, 2020 to 2035
  • Table 15: Europe - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Product, 2020 to 2035
  • Table 16: Europe - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Technology, 2020 to 2035
  • Table 17: Europe - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
  • Table 18: Europe - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 19: Asia Pacific - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 20: Asia Pacific - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Test Type, 2020 to 2035
  • Table 21: Asia Pacific - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Product, 2020 to 2035
  • Table 22: Asia Pacific - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Technology, 2020 to 2035
  • Table 23: Asia Pacific - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
  • Table 24: Asia Pacific - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 25: Latin America - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 26: Latin America - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Test Type, 2020 to 2035
  • Table 27: Latin America - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Product, 2020 to 2035
  • Table 28: Latin America - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Technology, 2020 to 2035
  • Table 29: Latin America - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
  • Table 30: Latin America - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 31: Middle East & Africa - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 32: Middle East & Africa - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Test Type, 2020 to 2035
  • Table 33: Middle East & Africa - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Product, 2020 to 2035
  • Table 34: Middle East & Africa - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Technology, 2020 to 2035
  • Table 35: Middle East & Africa - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
  • Table 36: Middle East & Africa - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035

List of Figures

  • Figure 01: Global Non-invasive Prenatal Testing Market Value Share Analysis, By Test Type, 2024 and 2035
  • Figure 02: Global Non-invasive Prenatal Testing Market Attractiveness Analysis, By Test Type, 2025 to 2035
  • Figure 03: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Cell-Free DNA Screening Test, 2020 to 2035
  • Figure 04: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Serum Marker Screening Test, 2020 to 2035
  • Figure 05: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Neural Tube Defects Test, 2020 to 2035
  • Figure 06: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Ultrasonography, 2020 to 2035
  • Figure 07: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Weight Management, 2020 to 2035
  • Figure 08: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Nutrition, 2020 to 2035
  • Figure 09: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 10: Global Non-invasive Prenatal Testing Market Value Share Analysis, By Product, 2024 and 2035
  • Figure 11: Global Non-invasive Prenatal Testing Market Attractiveness Analysis, By Product, 2025 to 2035
  • Figure 12: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Instruments, 2020 to 2035
  • Figure 13: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Kits & Reagents, 2020 to 2035
  • Figure 14: Global Non-invasive Prenatal Testing Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 15: Global Non-invasive Prenatal Testing Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 16: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Whole-Genome Sequencing, 2020 to 2035
  • Figure 17: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by SNP Analysis, 2020 to 2035
  • Figure 18: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Microarray Analysis, 2020 to 2035
  • Figure 19: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Rolling Circle Amplification, 2020 to 2035
  • Figure 20: Global Non-invasive Prenatal Testing Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 21: Global Non-invasive Prenatal Testing Market Attractiveness Analysis, By Indication, 2025 to 2035
  • Figure 22: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Down Syndrome (trisomy 21), 2020 to 2035
  • Figure 23: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Edwards syndrome (trisomy 18), 2020 to 2035
  • Figure 24: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Patau syndrome (trisomy 13), 2020 to 2035
  • Figure 25: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Turner Syndrom (Monosomy X/XO), 2020 to 2035
  • Figure 26: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Klinefelter Syndrome (XXY), 2020 to 2035
  • Figure 27: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Jacob's Syndrome (XYY), 2020 to 2035
  • Figure 28: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Gender Identification, 2020 to 2035
  • Figure 29: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 30: Global Non-invasive Prenatal Testing Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 31: Global Non-invasive Prenatal Testing Market Attractiveness Analysis, By End-user 2025 to 2035
  • Figure 32: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Hospitals, 2020 to 2035
  • Figure 33: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Diagnostics Laboratories, 2020 to 2035
  • Figure 34: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Specialty Clinics, 2020 to 2035
  • Figure 35: Global Non-invasive Prenatal Testing Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 36: Global Non-invasive Prenatal Testing Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 37: Global Non-invasive Prenatal Testing Market Attractiveness Analysis, By Region, 2025 to 2035
  • Figure 38: North America - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 39: North America - Non-invasive Prenatal Testing Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 40: North America - Non-invasive Prenatal Testing Market Attractiveness Analysis, by Country, 2025 to 2035
  • Figure 41: North America - Non-invasive Prenatal Testing Market Value Share Analysis, By Test Type, 2024 and 2035
  • Figure 42: North America - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Test Type, 2025 to 2035
  • Figure 43: North America - Non-invasive Prenatal Testing Market Value Share Analysis, By Product, 2024 and 2035
  • Figure 44: North America - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Product, 2025 to 2035
  • Figure 45: North America - Non-invasive Prenatal Testing Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 46: North America - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 47: North America - Non-invasive Prenatal Testing Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 48: North America - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Indication, 2025 to 2035
  • Figure 49: North America - Non-invasive Prenatal Testing Market Value Share Analysis, By End-user 2024 and 2035
  • Figure 50: North America - Non-invasive Prenatal Testing Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 51: Europe - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 52: Europe - Non-invasive Prenatal Testing Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 53: Europe - Non-invasive Prenatal Testing Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 54: Europe - Non-invasive Prenatal Testing Market Value Share Analysis, By Test Type, 2024 and 2035
  • Figure 55: Europe - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Test Type, 2025 to 2035
  • Figure 56: Europe - Non-invasive Prenatal Testing Market Value Share Analysis, By Product, 2024 and 2035
  • Figure 57: Europe - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Product, 2025 to 2035
  • Figure 58: Europe - Non-invasive Prenatal Testing Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 59: Europe - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 60: Europe - Non-invasive Prenatal Testing Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 61: Europe - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Indication, 2025 to 2035
  • Figure 62: Europe - Non-invasive Prenatal Testing Market Value Share Analysis, By End-user 2024 and 2035
  • Figure 63: Europe - Non-invasive Prenatal Testing Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 64: Asia Pacific - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 65: Asia Pacific - Non-invasive Prenatal Testing Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 66: Asia Pacific - Non-invasive Prenatal Testing Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 67: Asia Pacific - Non-invasive Prenatal Testing Market Value Share Analysis, By Test Type, 2024 and 2035
  • Figure 68: Asia Pacific - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Test Type, 2025 to 2035
  • Figure 69: Asia Pacific - Non-invasive Prenatal Testing Market Value Share Analysis, By Product, 2024 and 2035
  • Figure 70: Asia Pacific - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Product, 2025 to 2035
  • Figure 71: Asia Pacific - Non-invasive Prenatal Testing Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 72: Asia Pacific - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 73: Asia Pacific - Non-invasive Prenatal Testing Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 74: Asia Pacific - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Indication, 2025 to 2035
  • Figure 75: Asia Pacific - Non-invasive Prenatal Testing Market Value Share Analysis, By End-user 2024 and 2035
  • Figure 76: Asia Pacific - Non-invasive Prenatal Testing Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 77: Latin America - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 78: Latin America - Non-invasive Prenatal Testing Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 79: Latin America - Non-invasive Prenatal Testing Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 80: Latin America - Non-invasive Prenatal Testing Market Value Share Analysis, By Test Type, 2024 and 2035
  • Figure 81: Latin America - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Test Type, 2025 to 2035
  • Figure 82: Latin America - Non-invasive Prenatal Testing Market Value Share Analysis, By Product, 2024 and 2035
  • Figure 83: Latin America - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Product, 2025 to 2035
  • Figure 84: Latin America - Non-invasive Prenatal Testing Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 85: Latin America - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 86: Latin America - Non-invasive Prenatal Testing Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 87: Latin America - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Indication, 2025 to 2035
  • Figure 88: Latin America- Non-invasive Prenatal Testing Market Value Share Analysis, By End-user 2024 and 2035
  • Figure 89: Latin America - Non-invasive Prenatal Testing Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 90: Middle East & Africa - Non-invasive Prenatal Testing Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 91: Middle East & Africa - Non-invasive Prenatal Testing Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 92: Middle East & Africa - Non-invasive Prenatal Testing Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 93: Middle East & Africa - Non-invasive Prenatal Testing Market Value Share Analysis, By Test Type, 2024 and 2035
  • Figure 94: Middle East & Africa - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Test Type, 2025 to 2035
  • Figure 95: Middle East & Africa - Non-invasive Prenatal Testing Market Value Share Analysis, By Product, 2024 and 2035
  • Figure 96: Middle East & Africa - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Product, 2025 to 2035
  • Figure 97: Middle East & Africa - Non-invasive Prenatal Testing Market Value Share Analysis, By Technology, 2024 and 2035
  • Figure 98: Middle East & Africa - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Technology, 2025 to 2035
  • Figure 99: Middle East & Africa - Non-invasive Prenatal Testing Market Value Share Analysis, By Indication, 2024 and 2035
  • Figure 100: Middle East & Africa - Non-invasive Prenatal Testing Market Attractiveness Analysis, By Indication, 2025 to 2035
  • Figure 101: Middle East & Africa - Non-invasive Prenatal Testing Market Value Share Analysis, By End-user 2024 and 2035
  • Figure 102: Middle East & Africa - Non-invasive Prenatal Testing Market Attractiveness Analysis, By End-user, 2025 to 2035